PUBLICATIONS

Monitoring of coagulation factor therapy in patients with von Willebrand disease type 3 using a microchip flow chamber system

No.24
CitationThromb Haemost 117(01),p75-85(2017)
InstituteKarolinska University Hospital and Karolinska Institutet, Stockholm, Sweden
1st AuthorA Ågren
AR
PL
HD
Paper typesClinical investigations
Main
purpose
Drug efficacy evaluation
DiseaseVWD type3
Antiplatelet drug
Anticoagulant drug
Other drug
Clinical specimensVWD type3 patient
Animal
Keyword
PL Chip for T-TAS01 is available for in vitro diagnostic use only in the the United States and EU Copyright © 2021 FUJIMORI KOGYO CO.,LTD. All Rights Reserved.